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Spinal Cord Stimulators: 
an Introduction
Steven Falowski, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 
Background
Pain can be divided into two broad categories, nociceptive pain and neuropathic pain. Nociceptive 
pain is a dull, throbbing pain which results from irritated nerves after physical tissue injury. This is 
seen commonly in cancer or after a fracture. Nociceptive pain is amenable to treatment with pain 
medications such as opioids and/or anti-inflammatories. Neuropathic pain is described as burning, 
shooting, or shocking pain. This type of pain results from nerve damage or abnormal nerve conduc-
tion such as pain exhibited with failed back syndrome, post surgical pain, neuromas, shingles, and 
complex regional pain syndrome (previously called RSD or causalgia). Neuropathic pain tends to 
be resistant to treatment with pain medications. Neurostimulation has been an effective treatment 
option for the management of chronic neuropathic pain. It is a reversible therapy which can even be 
tested before permanent implantation.
Spinal cord stimulation (SCS) is an adjustable, non-destructive, neuromodulatory procedure which 
delivers therapeutic doses of electrical current to the spinal cord or to a targeted nerve. This low-
voltage stimulation can block the transmission of pain. The enthusiasm for SCS began with the 
introduction of the gate control theory for pain control by Melzack and Wall in 1965 1.They noted 
that stimulation of large myelinated fibers of peripheral nerves resulted in paresthesias and blocked 
the activity in small nociceptive projections.  In other words, pain receptors compete with each other 
and with other sensory afferents. Appropriate stimulation of a “rival” afferent can effectively block a 
pain signal. This is why rubbing your chin after its been hit relieves the pain – the bump is still present, 
but the rubbing blocks it. The SCS system is implanted in a space surrounding the spinal cord, called 
the epidural space, where it stimulates the dorsal columns which can mask the sensation of pain by 
producing a tingling sensation. 
Patient Selection
Some of the criteria listed below can be used to determine candidates for neurostimulation:
Conservative therapies have failed to adequately help the pain. 
Further traditional surgical intervention is not indicated. 
No serious untreated drug habituation for the pain condition exists. 
Psychological evaluation and clearance for implantation have been received, sorting out 
untreated depression or anxiety, addiction, or other behavioral disorders. 
No medical issues exist that would present problems with doing the surgery. 
Indications
The most common indications include post-laminectomy syndrome or failed back surgery syndrome 
(FBSS), complex regional pain syndrome (CRPS) or reflex sympathetic dystrophy (RSD), ischemic 
limb pain, and angina. Scattered reports regarding the treatment of intractable pain due to other 
causes including visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic 
neuralgia, and neurogenic thoracic outlet syndrome have also appeared in the literature.  
Surgical Technique
The procedures are most commonly performed by neurosurgeons or anesthesiologists specializing 
in pain management 2-5. A lead is temporarily utilized to cover a wide area for pain control. The 
lead, or electrode, is implanted into the epidural space. The lead is attached to a power source called 
the pulse generator (or commonly known as the battery). This is then connected to an outside or 
external system which is held in place by sterile dressings. The unit is then tested for efficacy during 
a screening period, which is usually 3-10 days.
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Figure 2
The patient received an implanted 
transverse tripole electrode in the thoracic 
spine. The new electrode has the ability 
of focusing the electrical field into the 
dorsal column to maximize the paresthesia 
into the back while avoiding painful 
stimulation of the nerves into the ribs.
Figure 1
A patient that had persistent 
neuropathic pain in his back and his 
legs despite anterior and posterior spinal 
reconstructive surgery.
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If relief is obtained at this point, the system may 
be implanted permanently. The stimulator is 
usually placed in an area where the skin will 
not be irritated and the unit will not be press-
ing against bone. The abdomen and buttocks 
are common locations.
Benefits
Neurostimulation has been shown to have a 
50% improvement in pain relief, reduce the use 
of medications, and allow the person experience 
an improvement in their quality of life 6-7. These 
benefits are expected to increase with improve-
ments in the technology and in understanding 
of how pain signals are generated and gated in 
the nervous system. It is important to realize 
that neurostimulation is a treatment option 
along the continuum of pain control.
Potential Adverse Effects
Surgical risks associated with an implant include 
hematoma, infection, and possible leakage of 
cerebrospinal fluid.  Because this is a device, 
there can be malfunction of the hardware or can 
have disruption in the settings by other signals; 
for example, patients with an SCS are advised 
to turn it off before going through an anti-theft 
device in a retail store; additionally, patients 
with an SCS can not undergo a magnetic reso-
nance imaging (MRI) scan.  
Summary
Spinal cord stimulation therapy has been avail-
able and approved for over two decades.  In 
the last five years, there have been significant 
advances in the technology: smaller, recharge-
able batteries; better electrodes; and improved 
implantation techniques.  More physicians are 
adapting this therapy in their practice for pain 
management and we are effectively improving 
patients’ lives.
The treatment of chronic pain remains chal-
lenging. Experience in the technique and the 
equipment has made SCS a much more reli-
able and safe modality.  Like all the modalities 
performed for chronic pain management, 
its results are favorable. It is important to 
remember that the goal of neurostimulation is 
to reduce pain, rather than to eliminate pain. 
Very few other invasive modalities can claim 
this success rate with a few years of follow-up. 
Spinal cord stimulation has earned a well estab-
lished and firm role in contemporary chronic 
pain management.
Further information is available at the Neural 
Interfaces Program Website of the NIH, http://
www.ninds.nih.gov/funding/research/npp/
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